Chloe Orkin

Professor Chloe Orkin is a Consultant Physician at Barts Health NHS Trust (since 2003) and Professor of Infection and Inequities at Queen Mary University of London (appointed 2019). She founded an international therapeutic trials unit that developed 20+ novel HIV therapies, including the FLAIR study on long-acting injectable HIV treatment (NEJM, 2020).

• Director, SHARE Collaborative
• Advisor to WHO Europe on mpox
• Past Chair, British HIV Association (2016-2019)
• President, Medical Women’s Federation

Research Focus: Inclusive clinical trial design, HIV inequities, blood-borne virus testing campaigns (e.g., Going Viral), and mpox outbreak management. Her work addresses gender, race, and age disparities in research participation and healthcare access.

Scientific Leadership: Key contributions to international mpox guidelines via SHARE-net collaborations and advocacy for the Undetectable = Untransmittable (U=U) campaign. She co-authored 15+ recent publications on long-acting HIV therapies, virological failure definitions, and pandemic-related health inequities.

Recognition:

• Top 100 LGBTQ+ Influencer (Diva Magazine, 2020)
• Disability Power Influencer Top 100 (Shaw Trust, 2023)

EDI Advocacy: Pioneering Athena Swan Chair, former Academic EDI Lead at Queen Mary, and frequent speaker on leadership, sexism, homophobia, and ableism in healthcare. She has published extensively on workforce and research inequities.